Nextera Enterprises, Inc. (OTCBB: NXRA) today reported financial results for the first quarter ended March 31, 2007 included in its Quarterly Report on Form 10-Q filed with the SEC. Net sales for the first quarter of 2007 were $2.4 million, an increase of $1.3 million or 122%, from $1.1 million recorded for the first quarter of 2006. Net sales for 2006 reflect the operating results of the Woodridge Labs business from the March�9, 2006 acquisition date forward. Woodridge Labs represents Nextera�s sole operations and generates all of its revenue. The 2007 net sales include a $0.2 million charge for expected returns related to the March 2007 voluntary recall of certain DermaFreeze365� products sold during the three months ended March 31, 2007. Gross profit and gross margins for the three months ended March 31, 2007 and 2006 were $1.3 million and 54% and $0.5 million and 51%, respectively. The 2007 gross profit includes a $0.2 million charge for expected returns related to the March 2007 product recall of related products sold during the three months ended March 31, 2007. Included within gross profit for the period ended March 31, 2006 is a $0.3 million charge associated with the amortization of the step up to fair value in the inventory acquired from Woodridge Labs, as required by related accounting literature. Selling, general and administrative expenses for the three months ended March 31, 2007 increased to $2.0 million or, 65%, from $1.2 million recorded for the same period last year. Selling, general and administrative expenses for the three months ending March 31, 2006 reflect the operating results of the Woodridge Labs business only from the March 9, 2006 acquisition to March 31, 2006. Included in the 2007 period expenses are approximately $0.2 million of general and administrative costs associated with the former corporate headquarters in Boston, Massachusetts, that are not expected to be recurring after the March 2007 relocation of the corporate headquarters to the Woodridge Labs facility in Panorama City, California. Net loss for the first quarter of 2007 was $1.3 million, or $0.03 per diluted common share, compared to $0.7 million, or $0.02 per diluted common share, for the first quarter of 2006. For the three months ended March 31, 2007, non-cash charges were $0.4 million, or $0.01 per share. Non-cash charges included $0.3 million of amortization of intangible assets and depreciation and $0.1 million for stock-based compensation. As of March 31, 2007, Nextera had cash on-hand of $0.4 million and outstanding debt under the Company�s credit facility was $11.7 million. Joe Millin, President of Nextera Enterprises, said, �We are continuing to manage through the DermaFreeze365� product recall and our retail partners have been very cooperative in supporting this core brand. Additionally, we look forward to launching new product lines with our retail partners in the second half of 2007.� About Nextera Enterprises, Inc. Nextera Enterprises Inc. operates through its wholly-owned subsidiary, Woodridge Labs, Inc. Woodridge Labs is an independent developer and marketer of branded consumer products that offer simple, effective solutions to niche personal care needs. More information can be found at www.nextera.com and www.woodridgelabs.com. Forward-Looking Statements This release contains forward-looking statements that involve risks and uncertainties, including, but not limited to, estimates of future performance. Actual results may differ materially from the results predicted, and reported results should not be considered an indication of future performance. Important factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements are detailed under �Item 1A.Risk Factors� and elsewhere in filings with the Securities and Exchange Commission made from time to time by Nextera, including, but not limited to: its Annual Report on Form 10-K for the year ended December 31, 2006 filed with the Securities and Exchange Commission on April 17, 2007; recent quarterly reports on Form 10-Q; and other current reports on Form 8-K. All forward-looking statements included in this news release should be considered in the context of these risk factors. Nextera undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Investors and prospective investors are cautioned not to place undue reliance on such forward-looking statements. Nextera Enterprises, Inc. Condensed Consolidated Statements of Operations (Amounts in thousands, except share amounts) (Unaudited) � Three Months Ended March 31, 2007� 2006� � Net sales $ 2,434� $ 1,096� Cost of sales 1,125� 540� Gross profit 1,309� 556� � Selling, general and administrative expenses 1,997� 1,212� Amortization of intangible assets 257� 31� Operating loss (945) (687) � Interest income 6� 125� Interest expense (282) (74) Loss from continuing operations before income taxes (1,221) (636) � Provision for income taxes 60� 29� Net loss (1,281) (665) � Preferred stock dividends (108) (84) Net loss applicable to common stockholders $ (1,389) $ (749) � Net loss per common share, basic and diluted Continuing operations $ (0.03) $ (0.02) � Weighted average common shares outstanding, basic and diluted 42,337� 35,940� Nextera Enterprises, Inc. Condensed Consolidated Balance Sheets (Amounts in thousands, except share amounts) � March 31, 2007 (Unaudited) December 31,2006 Assets Current assets: Cash and cash equivalents $ 434� $ 597� Inventories 2,186� 2,595� Due from supplier 24� 127� Prepaid expenses and other current assets 1,869� 260� Total current assets 4,513� 3,579� � Property and equipment, net 277� 284� Goodwill 8,969� 10,969� Intangible assets, net 12,814� 12,827� Other assets 382� 484� Total assets $ 26,955� $ 28,143� � Liabilities and Stockholders� Equity Current liabilities: Accounts payable and accrued expenses $ 4,324� $ 4,364� Current portion of long-term debt 250� �� Total current liabilities 4,574� 4,364� � Long-term debt 11,468� 11,718� � Deferred taxes 296� 236� Other long-term liabilities 1,334� 1,334� Total stockholders� equity 9,283� 10,491� Total liabilities and stockholders� equity $ 26,955� $ 28,143� Nextera Enterprises, Inc. Condensed Consolidated Statements of Cash Flows (Amounts in thousands; unaudited) � Three Months Ended March 31, 2007� 2006� Operating activities Net loss $ (1,281) $ (665) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation 14� 12� Amortization of intangible assets 257� 31� Provision for allowances and returns (91) �� Inventory write-down 21� �� Deferred taxes 60� �� Stock based compensation 81� 40� Change in operating assets and liabilities 529� 612� Net cash provided by (used in) operating activities (410) 30� � Investing activities Cash from acquisition escrow 500� (22,951) Purchase of licensing agreement (246) �� Purchase of fixed assets (7) �� Net cash provided by (used in) investing activities 247� (22,951) � Financing activities Borrowings under revolving credit facility �� 3,000� Borrowings under term note �� 10,000� Payment of note acquired in acquisition �� (1,000) Payment of debt issuance costs �� (480) Net cash provided by financing activities �� 11,520� � � Net decrease in cash and cash equivalents (163) (11,401) � Cash and cash equivalents at beginning of period 597� 15,043� Cash and cash equivalents at end of period $ 434� $ 3,642�
Nextera Enterprises (CE) (USOTC:NXRA)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Nextera Enterprises (CE) Charts.
Nextera Enterprises (CE) (USOTC:NXRA)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Nextera Enterprises (CE) Charts.